Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

AVEO Pharmaceuticals Inc. (AVEO)

0.71   -0.04 (-5.33%) 05-17 16:00
Open: 0.74 Pre. Close: 0.75
High: 0.7464 Low: 0.7
Volume: 2,027,871 Market Cap: 114M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.751 - 0.757 0.757 - 0.761
Low: 0.688 - 0.694 0.694 - 0.699
Close: 0.702 - 0.712 0.712 - 0.718

Technical analysis

as of: 2019-05-17 4:26:50 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 1.12     One year: 1.31
Support: Support1: 0.70    Support2: 0.58
Resistance: Resistance1: 0.96    Resistance2: 1.12
Pivot: 0.88
Moving Average: MA(5): 0.78     MA(20): 0.89
MA(100): 1.04     MA(250): 1.85
MACD: MACD(12,26): -0.04     Signal(9): -0.01
Stochastic oscillator: %K(14,3): 7.58     %D(3): 11.34
RSI: RSI(14): 35.36
52-week: High: 3.59  Low: 0.49  Change(%): -67.1
Average Vol(K): 3-Month: 718168  10-Days: 236571

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
AVEO has closed below the lower band by 5.5%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 55.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to AVEO's normal range. The bands have been in this narrow range for 17 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Sat, 11 May 2019 08:55:57 Z
AVEO Pharmaceuticals (AVEO) Q1 Earnings & Revenues Miss Mark

Fri, 10 May 2019 21:58:00 Z
AVEO Pharmaceuticals (AVEO) Q1 Earnings & Revenues Miss Mark

Thu, 09 May 2019 15:07:25 Z
AVEO Pharmaceuticals (AVEO) Reports Q1 Loss, Tops Revenue Estimates

Tue, 07 May 2019 16:15:05 Z
AVEO Pharmaceuticals (AVEO) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Thu, 02 May 2019 00:11:43 Z
AVEO Pharmaceuticals (AVEO) Dips More Than Broader Markets: What You Should Know

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 160.74
Shares Float (M) 158.40
% Held by Insiders
% Held by Institutions 47.50
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -0.310
EPS Est. Current Year -0.550
EPS Est. Next Year -0.420
EPS Est. Next Quarter -0.090
Forward EPS -0.450
Book Value (p.s.)
PEG Ratio
Profit Margin 82.61
Operating Margin -445.98
Return on Assets (ttm) -13.6
Return on Equity (ttm) 15.7
Qtrly Rev. Growth 57.0
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

P/E -2.29
P/E Growth Ratio -0.05
P/S 2282508032.00

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.